Paragon Biomedical - Advancing Research. Improving Life. Globally.

FOR IMMEDIATE RELEASE

CONTACT:
Jared Byer
Paragon Biomedical, Inc.
9685 Research Drive
Irvine, CA 92618
Phone: +1 913 980 0028
www.paragonbiomedical.com

PARAGON BIOMEDICAL’S INFECTIOUS DISEASE EXPERTS TO ATTEND ICAAC

Irvine, CA – Wednesday, September 9, 2009

Irvine, CA - Wednesday, September 9, 2009 Contract research organizations (CROs) provide essential support of global efforts to curb the toll of infectious disease on the world’s population, according to Gena Reed, founder and chief executive officer of Paragon Biomedical, a global, full-service CRO.

Reed said pharmaceutical, biotechnology, and medical device companies are eager to collaborate with experienced, therapeutically-focused CROs.

“That’s why the annual ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) meeting draws researchers from around the world,” she said. “Not only do we learn about the latest research, the conference also provides an excellent forum for vigorous, productive discussions on how to best manage research resources.”

“Like other sectors in the economy, clinical research is highly focused on resource management,” said Reed. “In my experience, the companies that most effectively manage their people, money, and time are the ones who consistently achieve their objectives.”

Paragon Biomedical attendees at ICAAC include executive team members and senior global operations leadership.

Paragon Biomedical’s therapeutic focus includes Phase I - IV infectious disease studies. The company’s global presence provides 24/7 service in nearly all of the world’s regions.

###